Fosun Pharma unit, BioNTech to set up JV for COVID-19 vaccine production

 China's Shanghai Fosun Pharmaceutical said on Sunday its subsidiary had agreed to set up a joint venture with BioNTech for the manufacture and commercialisation of the German firm's COVID-19 vaccine.

Fosun Pharmaceutical Industrial will provide a manufacturing facility with an annual capacity of up to 1 billion doses of BioNTech's COVID-19 vaccine, while BioNTech agreed to license relevant manufacturing technology and know-how to the JV, in which the two firms will hold 50% stake each, Shanghai Fosun Pharma said in a filing.

https://www.marketscreener.com/quote/stock/SHANGHAI-FOSUN-PHARMACEUT-6548924/news/Shanghai-Fosun-Pharmaceutical-nbsp-Fosun-Pharma-s-subsidiary-BioNTech-to-set-up-JV-for-COVID-19-v-33204670/